Production (Stage)
AIM ImmunoTech Inc.
AIM
$9.09
-$0.2665-2.85%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.21M | -17.32M | -23.93M | -28.05M | -31.12M |
| Total Depreciation and Amortization | 246.00K | 246.00K | 240.00K | 230.00K | 249.00K |
| Total Amortization of Deferred Charges | 292.00K | 301.00K | 232.00K | 270.00K | 73.00K |
| Total Other Non-Cash Items | 1.92M | 1.59M | 1.80M | 1.78M | 770.00K |
| Change in Net Operating Assets | 320.00K | 296.00K | 963.00K | 2.51M | 7.62M |
| Cash from Operations | -12.43M | -14.89M | -20.69M | -23.25M | -22.40M |
| Capital Expenditure | -18.00K | -18.00K | -8.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | 47.00K | 12.00K | 18.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.78M | 4.72M | 749.00K | 106.00K | -930.00K |
| Cash from Investing | 5.76M | 4.71M | 788.00K | 118.00K | -912.00K |
| Total Debt Issued | 0.00 | 2.50M | 2.50M | 2.37M | 2.50M |
| Total Debt Repaid | -251.00K | -251.00K | -- | -- | -- |
| Issuance of Common Stock | 1.22M | 892.00K | 1.01M | 1.24M | 714.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.30M | 3.30M | 2.05M | 2.05M | -- |
| Cash from Financing | 4.28M | 6.44M | 5.55M | 5.65M | 3.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.40M | -3.74M | -14.35M | -17.48M | -20.10M |